The global insulin pumps market was valued at USD 5.30 Billion in 2025 and is expected to grow at a CAGR of 6.20%, reaching USD 9.67 Billion by 2035. The market growth is driven by the growing prevalence of diabetes, increasing awareness of advanced insulin delivery systems, and expanding access to healthcare technology across the globe. Technological innovations such as tubeless and smartphone-integrated pumps are supporting adoption. Rising demand in emerging economies and favourable reimbursement policies are anticipated to boost market value during the forecast period.
Base Year
Historical Period
Forecast Period
In September 2024, Embecta received FDA clearance for its disposable patch pump designed for people with type 2 diabetes, a move expected to significantly drive the market growth by addressing high-dose insulin needs.
The integration of insulin pumps with dual glucose-ketone sensors is a key trend in the market. For instance, in June 2025, Tandem Diabetes Care partnered with Abbott to enhance diabetes management and reduce the risks of diabetic ketoacidosis.
The key players in the insulin pump market are driving growth through continuous innovation, strategic partnerships, and expanding global access to advanced diabetes management solutions, significantly improving patient outcomes and enhancing user-friendly, automated insulin delivery systems.
Compound Annual Growth Rate
6.2%
Value in USD Billion
2026-2035
*this image is indicative*
Insulin pumps play a vital role in advanced diabetes management by providing continuous and precise insulin delivery, helping patients maintain better glycemic control and reduce complications. The market is experiencing significant growth, driven by the rising prevalence of diabetes, technological advancements, and increasing patient awareness. The market is poised to grow at a CAGR of 6.20% during the forecast period of 2026–2035. The increasing adoption of wearable medical devices, favorable reimbursement policies, and the growing demand for minimally invasive treatment options further support the market expansion across both developed and emerging economies.
Rising Diabetes Prevalence and Healthcare Costs to Accelerate Market Growth
The increasing global burden of diabetes is a significant driver accelerating the growth of the market. According to the International Diabetes Federation's 2021 report, around 537 million people worldwide were living with diabetes, representing approximately 10.5% of the global population. This condition accounted for USD 966 billion in healthcare spending. The number of individuals with diabetes is projected to reach 783 million by 2045, with healthcare costs exceeding USD 1,054 billion. This escalating prevalence continues to fuel demand for advanced insulin delivery systems, thereby supporting market expansion.
The market is experiencing several emerging trends, including the transformative impact of implantable insulin pumps on advanced diabetes care and significant breakthroughs in the longevity of continuous glucose monitoring (CGM) systems.
Implantable Insulin Pumps to Revolutionize Advanced Diabetes Care, Enhancing Market Value
The advancement of implantable insulin pump technologies aimed at addressing unmet needs in complex type 1 diabetes cases is a notable trend in the market. For instance, in May 2025, Isala Hospital in the Netherlands became the first in the world to implant an updated insulin pump developed by Medtronic, marking the launch of the international Phoenix study. This innovation targets patients unresponsive to conventional therapies, offering improved glucose control and quality of life. Such a trend is expected to significantly boost market growth through expanded treatment capabilities.
Breakthrough in CGM Longevity to Elevate the Insulin Pumps Market Value
The rising integration of advanced continuous glucose monitoring (CGM) technologies with insulin pumps is shaping a transformative trend in diabetes care. In September 2024, the U.S. FDA granted clearance to the Eversense 365, the world’s first CGM system designed for year-long use. This milestone introduced a long-term, implantable solution that reduces sensor changes and enhanced patient convenience. As such innovations continue aligning with automated insulin delivery systems, the trend is expected to significantly enhance the growth trajectory of the global market.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Patch-Type Insulin Pumps to Lead the Market Segmentation by Product Type
The market comprises various product types, including traditional insulin pumps and insulin pump supplies, and accessories. Among these, insulin pumps are expected to dominate the market due to their compact design, user comfort, and technological advancement. For instance, in July 2024, CareMedi’s CareLevo, in collaboration with Silicon Labs, launched a wireless BG22 SoC. Featuring a 3 mL reservoir, smartphone app integration, and enhanced energy efficiency, CareLevo sets a new benchmark in precision insulin delivery. Its lightweight, waterproof, and user-friendly design addresses key patient needs, reinforcing patch-type insulin pumps’ leadership in the evolving diabetes care landscape.
The regions included in the report are North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Among these, North America is expected to hold a significant share in the market, driven by high diabetes prevalence, technological advancements, early adoption of innovative treatment options, and regulatory support for biosimilar insulin products. For instance, in July 2025, Biocon Biologics received U.S. FDA approval for KIRSTY, the first and only interchangeable rapid-acting Insulin Aspart in the United States. KIRSTY is indicated to improve glycemic control in adults and pediatric patients and will be available as a prefilled pen and a multiple-dose vial. Such developments enhance insulin accessibility, broaden treatment choices, and underscore North America’s continued leadership in delivering advanced and affordable diabetes care solutions.
The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Insulet Corporation, a leading innovator in tubeless insulin pump technology, has expanded its impact in the market with the Omnipod® 5 automated insulin delivery system. In August 2024, the FDA-cleared Omnipod 5 for both type 1 and type 2 diabetes, making it the first and only AID system of its kind. It enhances diabetes management through automated insulin delivery, significantly improving patient outcomes. Insulet continues to drive accessibility, convenience, and clinical advancement in insulin therapy.
Medtronic plc, a global leader in healthcare technology, is actively shaping the insulin pumps market through innovative diabetes care solutions. In April 2025, the company submitted 510(k) applications to the U.S. FDA for its MiniMed™ 780G insulin pump and SmartGuard™ algorithm. These interoperable technologies, developed in partnership with Abbott, aim to enhance automated insulin delivery and strengthen Medtronic's presence in advanced diabetes management.
F. Hoffmann-La Roche AG is a global healthcare leader with experience in diabetes care. Through its Accu-Chek® and mySugr® brands, the company offers a comprehensive range of glucose monitoring and insulin delivery systems. Roche is actively involved in the global insulin pumps market by providing integrated, personalized diabetes management (iPDM) solutions that enhance digital monitoring and improve patient outcomes worldwide.
Tandem Diabetes Care, Inc., a leading U.S.-based diabetes technology company, is actively shaping the insulin pumps market through its advanced automated insulin delivery systems. Its flagship products, the t:slim X2 and Tandem Mobi insulin pumps, utilize Control-IQ+ technology, recently FDA-cleared in February 2025 for type 2 diabetes. This advancement reinforces the company’s commitment to expanding insulin pump accessibility and improving diabetes management outcomes.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market are Ypsomed AG, Ascensia Diabetes Care India Private Limited, Sooil Development Co., Ltd., Valeritas, Inc., and JingasuDelfu Co., Ltd.
Market Breakup by Product Type
Market Breakup by Indication
Market Breakup by Distribution Channel
Market Breakup by Region
Upto 15% Off
USD
$3299 $2969
$5499 $4949
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Indication |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share